PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,946,915 | -27.2% | 1,041,131 | 0.0% | 0.63% | -30.7% |
| Q3 2022 | $2,676,000 | +33.9% | 1,041,131 | 0.0% | 0.92% | +43.0% |
| Q2 2022 | $1,999,000 | -35.1% | 1,041,131 | 0.0% | 0.64% | -26.8% |
| Q1 2022 | $3,082,000 | -33.8% | 1,041,131 | 0.0% | 0.87% | -22.5% |
| Q4 2021 | $4,654,000 | -8.0% | 1,041,131 | 0.0% | 1.13% | -1.7% |
| Q3 2021 | $5,060,000 | -28.6% | 1,041,131 | 0.0% | 1.15% | -47.6% |
| Q2 2021 | $7,090,000 | -3.3% | 1,041,131 | 0.0% | 2.19% | -13.4% |
| Q1 2021 | $7,330,000 | +12.5% | 1,041,131 | 0.0% | 2.53% | +13.6% |
| Q4 2020 | $6,517,000 | +15.9% | 1,041,131 | 0.0% | 2.23% | +85.3% |
| Q3 2020 | $5,622,000 | +3.7% | 1,041,131 | 0.0% | 1.20% | -20.7% |
| Q2 2020 | $5,424,000 | +67.5% | 1,041,131 | 0.0% | 1.52% | -29.4% |
| Q1 2020 | $3,238,000 | -22.6% | 1,041,131 | 0.0% | 2.15% | +6.3% |
| Q4 2019 | $4,185,000 | -7.2% | 1,041,131 | 0.0% | 2.02% | -29.0% |
| Q3 2019 | $4,508,000 | +9.3% | 1,041,131 | 0.0% | 2.85% | +80.3% |
| Q2 2019 | $4,123,000 | -26.3% | 1,041,131 | 0.0% | 1.58% | -68.4% |
| Q1 2019 | $5,591,000 | +4.7% | 1,041,131 | 0.0% | 5.00% | +3.1% |
| Q4 2018 | $5,341,000 | -46.8% | 1,041,131 | 0.0% | 4.85% | -18.8% |
| Q3 2018 | $10,047,000 | -4.9% | 1,041,131 | 0.0% | 5.97% | -1.1% |
| Q2 2018 | $10,567,000 | -21.9% | 1,041,131 | 0.0% | 6.04% | -28.3% |
| Q1 2018 | $13,535,000 | -27.4% | 1,041,131 | 0.0% | 8.41% | -37.7% |
| Q4 2017 | $18,636,000 | -28.7% | 1,041,131 | 0.0% | 13.50% | -25.4% |
| Q3 2017 | $26,132,000 | -16.4% | 1,041,131 | -19.9% | 18.09% | -27.3% |
| Q2 2017 | $31,275,000 | +24.8% | 1,300,432 | -0.1% | 24.89% | +33.3% |
| Q1 2017 | $25,052,000 | +25.4% | 1,301,413 | 0.0% | 18.66% | +11.8% |
| Q4 2016 | $19,977,000 | +18.1% | 1,301,413 | 0.0% | 16.70% | +3.0% |
| Q3 2016 | $16,918,000 | -6.5% | 1,301,413 | 0.0% | 16.22% | -14.5% |
| Q2 2016 | $18,103,000 | -8.1% | 1,301,413 | 0.0% | 18.96% | +3.5% |
| Q1 2016 | $19,703,000 | -20.2% | 1,301,413 | 0.0% | 18.31% | +22.9% |
| Q4 2015 | $24,688,000 | -0.1% | 1,301,413 | 0.0% | 14.90% | +3.3% |
| Q3 2015 | $24,701,000 | -26.3% | 1,301,413 | 0.0% | 14.43% | -5.2% |
| Q2 2015 | $33,524,000 | -16.3% | 1,301,413 | 0.0% | 15.22% | -10.7% |
| Q1 2015 | $40,057,000 | -19.8% | 1,301,413 | 0.0% | 17.03% | +20.0% |
| Q4 2014 | $49,974,000 | – | 1,301,413 | – | 14.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,339,107 | $10,502,000 | 3.20% |
| Telemetry Investments, L.L.C. | 262,279 | $1,178,000 | 1.52% |
| Bruce & Co., Inc. | 1,443,312 | $6,480,000 | 1.30% |
| Omega Fund Management, LLC | 1,971,241 | $8,851,000 | 1.25% |
| Worth Venture Partners, LLC | 556,832 | $2,500,000 | 1.24% |
| Abingworth LLP | 1,041,131 | $4,654,000 | 1.13% |
| 1492 Capital Management LLC | 491,033 | $2,205,000 | 1.09% |
| CM Management, LLC | 300,000 | $1,347,000 | 1.02% |
| Trellus Management Company, LLC | 295,000 | $1,325,000 | 0.88% |
| GENERAL AMERICAN INVESTORS CO INC | 1,306,919 | $5,868,000 | 0.46% |